Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1018083.RAh-l-Rhwtr5onkTjEq59juPnlcVtmIPnpTF6Q9Sl9DBQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1018083.RAh-l-Rhwtr5onkTjEq59juPnlcVtmIPnpTF6Q9Sl9DBQ130_assertion type Assertion NP1018083.RAh-l-Rhwtr5onkTjEq59juPnlcVtmIPnpTF6Q9Sl9DBQ130_head.
- NP1018083.RAh-l-Rhwtr5onkTjEq59juPnlcVtmIPnpTF6Q9Sl9DBQ130_assertion description "[To test whether the HES1-derived NSCs can be used for cancer gene therapy, we used a baculoviral vector to introduce the herpes simplex virus thymidine kinase suicide gene into the cells and demonstrated that baculovirus-mediated transgene expression may last for at least 3 weeks in NSCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1018083.RAh-l-Rhwtr5onkTjEq59juPnlcVtmIPnpTF6Q9Sl9DBQ130_provenance.
- NP1018083.RAh-l-Rhwtr5onkTjEq59juPnlcVtmIPnpTF6Q9Sl9DBQ130_assertion evidence source_evidence_literature NP1018083.RAh-l-Rhwtr5onkTjEq59juPnlcVtmIPnpTF6Q9Sl9DBQ130_provenance.
- NP1018083.RAh-l-Rhwtr5onkTjEq59juPnlcVtmIPnpTF6Q9Sl9DBQ130_assertion SIO_000772 21633393 NP1018083.RAh-l-Rhwtr5onkTjEq59juPnlcVtmIPnpTF6Q9Sl9DBQ130_provenance.
- NP1018083.RAh-l-Rhwtr5onkTjEq59juPnlcVtmIPnpTF6Q9Sl9DBQ130_assertion wasDerivedFrom befree-20150227 NP1018083.RAh-l-Rhwtr5onkTjEq59juPnlcVtmIPnpTF6Q9Sl9DBQ130_provenance.
- NP1018083.RAh-l-Rhwtr5onkTjEq59juPnlcVtmIPnpTF6Q9Sl9DBQ130_assertion wasGeneratedBy ECO_0000203 NP1018083.RAh-l-Rhwtr5onkTjEq59juPnlcVtmIPnpTF6Q9Sl9DBQ130_provenance.